Palo Alto, California 94303


The investigators have developed an image analysis method that can predict the likelihood that a patient with age related macular degeneration (AMD) will progress within 1 year, based on computerized analysis of optical coherence tomography (OCT) images that are routinely acquired in clinical practice on each patient visit to the ophthalmologist. The investigators' goal is to evaluate whether this method will improve the ability to detect AMD earlier and improve visual outcomes in AMD patients by assigning patient risk categories and having patients come back for follow up based on those categories.


Inclusion Criteria: - Non-exudative age-related macular degeneration Exclusion Criteria: - Exudative age-related macular degeneration



Primary Contact:

Theodore Leng, MD
Phone: 650-723-6995

Backup Contact:


Location Contact:

Palo Alto, California 94303
United States

Theodore Leng, MD
Phone: 650-723-6995

Site Status: Recruiting

Data Source:

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.